Comment on Domzaridou et al .: Recognising the complexities of co‐prescriptions and lifestyle factors in opioid agonist treatment

Ähnliche Einträge

• Recognizing the complexities of co‐prescriptions and life‐style factors in opioid agonist treatment: A response from Eleni Domzaridou, Matthew J. Carr, Tim Millar, Roger T. Webb and Darren M. Ashcroft
  von: Eleni Domzaridou, et al.
  Veröffentlicht: (2024)
• Commentary on Young et al .: Clinical guidance is required for stimulant co‐prescription with opioid agonist therapy
  von: Nadine Ezard, et al.
  Veröffentlicht: (2025)
• Retention in opioid agonist treatment during pregnancy and variations according to treatment and maternal characteristics
  von: Bianca Varney, et al.
  Veröffentlicht: (2026)
• Relative risks of adverse effects across different opioid agonist treatments—A systematic review and meta‐analysis
  von: Maximilian Meyer, et al.
  Veröffentlicht: (2025)
• Prescribing practices in opioid agonist treatment and changes in compliance to clinical dosing guidelines in British Columbia, Canada
  von: Brenda Carolina Guerra‐Alejos, et al.
  Veröffentlicht: (2024)